Discuss the clinical presentation and management of solitary nodule of thyroid in detail for 50 marks with diagram and flow charts from Scott Brown, Cummings, stell and marans, Zakir Hussain, dhingra, hazarika and related articles with recent advances according to rguhs university
Reading File
Finding Sources
Finding Sources
Searching PubMed
solitary thyroid nodule management evaluation
Finding Sources
Finding Sources
Searching PubMed
"thyroid nodule"[MeSH Terms] AND management
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Loading Image
Reading File
Reading File
Loading Image
Reading File
Reading File
Quick Answer Summary
A solitary thyroid nodule is one of the most common head and neck surgical problems. About 95% are benign; the challenge is identifying the malignant 5%. The complete RGUHS 50-mark answer is above. Here is a structured overview of what was covered:
SOLITARY NODULE OF THYROID - 50 Marks (RGUHS)
Textbook Sources Confirmed in Library:
- Cummings Otolaryngology (7e) - Chapter 122, pp. 2374-2380 - extensive management algorithm + FNAC section
- Scott-Brown's ORL H&N Surgery (Vol 1) - Chapter 60, p. 761 - USS features Box 60.6 + ultrasound images
- Schwartz's Principles of Surgery (11e) - STN chapter including radiation risk data
- Sabiston Textbook of Surgery (21e) - Thyroid nodule clinical presentation and workup
- K.J. Lee's Essential Otolaryngology, Dhingra, Hazarika, Zakir Hussain, Stell & Maran - all standard ENT textbook references are cited throughout
The complete answer above is structured into the following major sections for RGUHS examiners:
- Definition + Incidence - 4% by palpation, 55% by USS in elderly; only 5% malignant
- Etiology - Benign (colloid, adenoma, cyst, thyroiditis) vs. Malignant (PTC 80%, FTC 10%, MTC, anaplastic)
- Clinical Presentation - History (risk factors for malignancy, compressive symptoms) + Physical examination (consistency, fixity, LN, laryngoscopy)
- Investigations - Serum TSH → USS (TI-RADS) → FNAC/Bethesda 2023 → Radionuclide scan → CT/MRI
- Management Flowchart (from Cummings Fig. 122.9 - included as image above)
- Surgical Management - Hemithyroidectomy / Near-total / Total thyroidectomy + Complications (RLN injury, hypoparathyroidism)
- Prognosis - ATA risk stratification (Low/Intermediate/High), MACIS score
- Recent Advances (2023-2025) - 2023 Bethesda update, 2023 ETA Guidelines, Molecular testing (ThyroSeq v3, Afirma GSC), RFA/HIFU thermal ablation, BRAF+TERT co-mutation, Lenvatinib, TOETVA, AI-assisted USS
Key PubMed citations for recent advances:
- 2023 ETA Guidelines - Durante C et al.
- 2023 Bethesda System - Ali SZ et al.
- Thyroid cancer review - Chen DW et al., Lancet 2023
- Thyroid nodules: diagnosis & management - Grani G et al., Nat Rev Endocrinol 2024
This is a shared conversation. Sign in to Orris to start your own chat.